Collaboration with Leading Research Institution Provides Cutting-Edge Research in Radiation Oncology Methods and Systems SUNNYVALE, Calif. , March 30, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today the signing of a multi-year master
An industry first, PlanTouch enables both review and approval of radiation treatment plans on the iPad® SUNNYVALE, Calif. , March 26, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today the release of PlanTouch™, the first commercially
Award Underscores Accuray's Continued Progress in Optimizing Integration Efforts SUNNYVALE, Calif. , March 19, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that it has been awarded the 2012 Industry Excellence Award by Microsoft®
First Company to Receive Omega's Prestigious NorthFace ScoreBoard Award(SM) for Excellence in Both Customer Satisfaction and Net Promoter Score for Loyalty SUNNYVALE, Calif. , Feb. 29, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today
Availability of Industry-Leading Radiosurgery System at Japan’s Foremost Cancer Center Extends Accuray’s Market Share in Japan SUNNYVALE, Calif. , Feb. 27, 2012 /PRNewswire/ Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced installation of the CyberKnife®
SUNNYVALE, Calif., Feb. 27, 2012 /PRNewswire via COMTEX/ --Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its president and chief executive officer, Euan S. Thomson , Ph.D., is scheduled to present at the Cowen and Company Healthcare Conference in
SUNNYVALE, Calif. , Feb. 15, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the Citi 2012 Global Health Care Conference in New York City on Tuesday, February 28, 2012 at 11:00 a.m.
Achieves Solid Revenue, Positive Service Margins and Positive Cash Flow Integration Performance Metrics Ahead of Plan; Remains on Track for Return to Profitability SUNNYVALE, Calif. , Feb. 8, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced
CyberKnife System Broadens Range of Lung Cancer Patients Treatable with SBRT SUNNYVALE, Calif. , Jan. 26, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today publication of a study demonstrating the benefits of the CyberKnife® Robotic
SUNNYVALE, Calif. , Jan. 18, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced that it will report results for its second quarter of fiscal year 2012, ended December 31, 2011 on Wednesday, February 8, 2012 after the market closes.
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
